Condition: Depression · Depression, Postpartum · Anxiety in Pregnancy · Sponsor: BlueSkeye AI
This trial will assess the safety, feasibility, acceptability, usability and agreement with validated scales of an automated mood monitoring App (TrueBlue), in adult, perinatal participants (recruited between 12 weeks of pregnancy and 12 weeks post-partum), recruited across multiple sites in Nottinghamshire, United Kingdom (UK). An initial within-study pilot phase will assess key aspects of the study including recruitment rate, usability issues and a detailed understanding of any device related adverse events; prior to full recruitment of a total 125 participants over a total 14-month period.
This description comes directly from the study's public registry record.
John Michaelis, BSc · 01689 856664 · john@blueskeye.com
Neil Nixon, MBBS · 0115 969 1300 · Neil.Nixon@nottshc.nhs.uk
Always discuss trial participation with your own doctor first.
| Nottingham University Hospitals NHS Trust | Nottingham, Nottinghamshire, United Kingdom | Not Yet Recruiting |
| Nottinghamshire Healthcare NHS Foundation Trust | Nottingham, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06364488